Heidi Zod joined BELLUS Health in November 2020 and leads the global commercial organization in strategic planning, market readiness and launch commercialization.
Ms. Zod brings over 25 years of Pharmaceutical Marketing experience, both globally and in US markets across multiple therapeutic areas. She is a passionate, innovative strategic leader with expertise in bringing novel, first-in-disease assets through product development, planning, strategy, commercialization and market access.
Prior to joining Bellus, Ms. Zod was the Global Marketing Lead at Novo Nordisk where she was responsible for driving commercial strategic planning of the lead GLP-1 asset into NASH, as well as heading commercial U.S. pipeline development in diabetes and obesity. Prior to that Heidi rose through a variety of Marketing roles at Merck, leading programs to launch first-in-class molecules in hepatitis C and oncology and working directly with National Payers to contract and retain access across the full Merck portfolio of agents.
Ms. Zod holds a Masters of Business Administration from Rutgers University and a BA in Food Chemistry Science from Pennsylvania State University.